{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:06:39Z","timestamp":1793505999006,"version":"4.5.0"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejphar.2022.175031","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T01:59:56Z","timestamp":1652493596000},"page":"175031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Drug repurposing: An emerging strategy in alleviating skin cancer"],"prefix":"10.1016","volume":"926","author":[{"given":"Popat","family":"Kumbhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Kole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejashree","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Bhavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Waghmare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Bhokare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arehalli","family":"Manjappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Chellappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Salawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Disouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Patravale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/13543784.10.3.547","article-title":"Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug","volume":"10","author":"Agrawal","year":"2001","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib2","first-page":"397","article-title":"Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics","volume":"15","author":"Alan","year":"2020","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrd.2018.92","article-title":"Overcoming the legal and regulatory barriers to drug repurposing","volume":"18","author":"Alasdair","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijmedinf.2015.01.013","article-title":"Evaluation of usage patterns and user perception of the drug-drug interaction database SFINX","volume":"84","author":"Andersson","year":"2015","journal-title":"Int. J. Med. Inform."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.pharep.2016.06.004","article-title":"N-pentyl-nitrofurantoin induces apoptosis in HL-60 leukemia cell line by upregulating BAX and downregulating BCL-xL gene expression","volume":"68","author":"Andrade","year":"2016","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2014.04.005","article-title":"Inhibition of Wnt\/\u03b2-catenin pathway by niclosamide: a therapeutic target for ovarian cancer","volume":"134","author":"Arend","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neo.2017.01.010","article-title":"Digoxin plus trametinib therapy achieves disease control in BRAF wild-type metastatic melanoma patients","volume":"19","author":"Arthur","year":"2017","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.ejphar.2022.175031_bib8","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1158\/1535-7163.MCT-13-0948","article-title":"Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling","volume":"13","author":"Balic","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"issue":"19","key":"10.1016\/j.ejphar.2022.175031_bib9","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","article-title":"Beta blockers and breast cancer mortality: a population- based study","volume":"29","author":"Barron","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib10","first-page":"1727","article-title":"Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53\/Bax\/Bcl-2 signaling pathway","author":"Beberok","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"15","key":"10.1016\/j.ejphar.2022.175031_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2018.08.002","article-title":"GSH depletion, mitochondrial membrane breakdown, caspase-3\/7 activation and DNA fragmentation in U87MG glioblastoma cells: new insight into the mechanism of cytotoxicity induced by fluoroquinolones","volume":"835","author":"Beberok","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"55","key":"10.1016\/j.ejphar.2022.175031_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tiv.2018.12.002","article-title":"Moxifloxacin as an inducer of apoptosis in melanoma cells: a study at the cellular and molecular level","author":"Beberok","year":"2019","journal-title":"Toxicol. Vitro"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pharep.2017.07.007","article-title":"Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells","volume":"70","author":"Beberok","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2022.175031_bib14","first-page":"10","article-title":"Treatment of congestive heart failure--current status of use of digitoxin","volume":"31","author":"Belz","year":"2001","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR gamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib202","first-page":"394","article-title":"Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"17","key":"10.1016\/j.ejphar.2022.175031_bib16","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1002\/cam4.2594","article-title":"Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma","volume":"8","author":"Bustamante","year":"2019","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib17","first-page":"3853","article-title":"The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression","volume":"9","author":"Cai","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib18","first-page":"5","article-title":"Anthelmintic flubendazole and its potential use in anticancer therapy","volume":"60","author":"\u010c\u00e1\u0148ov\u00e1","year":"2017","journal-title":"Acta Med."},{"key":"10.1016\/j.ejphar.2022.175031_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tiv.2017.10.025","article-title":"Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells","volume":"46","author":"\u010c\u00e1\u0148ov\u00e1","year":"2018","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejphar.2022.175031_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.colsurfb.2018.04.031","article-title":"Repurposing itraconazole to the benefit of skin cancer treatment: a combined azole-DDAB nanoencapsulation strategy","volume":"167","author":"Carbone","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"D1","key":"10.1016\/j.ejphar.2022.175031_bib21","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gks1158","article-title":"The BioGRID interaction database: 2013 update","volume":"41","author":"Chatr-aryamontri","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2022.175031_bib22","article-title":"Network-based inference methods for drug repositioning","volume":"130620","author":"Chen","year":"2015","journal-title":"Comput. Math. Methods Med."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175031_bib23","doi-asserted-by":"crossref","first-page":"17593","DOI":"10.18632\/oncotarget.4307","article-title":"The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib24","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1002\/jcb.27927","article-title":"Lidocaine inhibits melanoma cell proliferation by regulating ERK phosphorylation","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1470320314535275","article-title":"Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma","volume":"16","author":"Chen","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.ejphar.2022.175031_bib26","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2147\/DDDT.S252626","article-title":"Leflunomide inhibits proliferation and induces apoptosis via suppressing autophagy and PI3K\/Akt signaling pathway in human bladder cancer cells","volume":"14","author":"Cheng","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jcp.25092","article-title":"Selective \u03b22-AR blockage suppresses colorectal cancer growth through regulation of EGFR-Akt\/ERK1\/2 signaling, G1-phase arrest, and apoptosis: \u03922-Ar signal and expression in crc progression","volume":"231","author":"Chin","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib28","first-page":"4827","article-title":"Capsaicin induces apoptosis and autophagy in human melanoma cells","volume":"17","author":"Chu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"60","key":"10.1016\/j.ejphar.2022.175031_bib29","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.18632\/oncotarget.27266","article-title":"The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes","volume":"10","author":"Coperchini","year":"2019","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib30","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3390\/ijms21082956","article-title":"Cutaneous squamous cell carcinoma: from biology to therapy","volume":"21","author":"Corchado-Cobos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.175031_bib31","article-title":"Repurposing of drug candidates for treatment of skin cancer","volume":"10","author":"Cort\u00e9s","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2022.175031_bib32","doi-asserted-by":"crossref","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: a database of reactions, pathways and biological processes","volume":"39","author":"Croft","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.ejphar.2022.175031_bib33","doi-asserted-by":"crossref","first-page":"21674","DOI":"10.18632\/oncotarget.15535","article-title":"Genistein inhibits the growth and regulates the migration and invasion abilities of melanoma cells via the FAK\/paxillin and MAPK pathways","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib34","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.3390\/ijms14024185","article-title":"Phenotypic identification of the redox dye methylene blue as an antagonist of heat shock response gene expression in metastatic melanoma cells","volume":"14","author":"Davis","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib35","article-title":"Effect of coadministration of propranolol and etodolac (VT-122) plus sorafenib for patients with advanced hepatocellular carcinoma (HCC)","volume":"33","author":"de la Torre","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2022.175031_bib36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1186\/1471-2407-14-567","article-title":"A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells","volume":"14","author":"Deb","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2022.175031_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jconrel.2021.05.009","article-title":"Microneedles for gene and drug delivery in skin cancer therapy","volume":"335","author":"Defu","year":"2021","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.ejphar.2022.175031_bib38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41419-020-02742-0","article-title":"Itraconazole inhibits the Hedgehog signaling pathway thereby inducing autophagy-mediated apoptosis of colon cancer cells","volume":"11","author":"Deng","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib39","first-page":"55","article-title":"Department of pharmacology kempegowda institute of medical sciences Bangalore, India. An overview of drug repurposing: review article","volume":"7","author":"Dey","year":"2019","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.ejphar.2022.175031_bib40","doi-asserted-by":"crossref","first-page":"103792","DOI":"10.1016\/j.bioorg.2020.103792","article-title":"Dexamethasone simulates the anticancer effect of nano-formulated paclitaxel in breast cancer cells","volume":"99","author":"Diab","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175031_bib41","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3390\/ijms22073682","article-title":"Inhibition effect of chloroquine and integrin-linked kinase knockdown on translation in melanoma cells","volume":"22","author":"Dorota","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CAD.0b013e32835a43f1","article-title":"XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts","volume":"24","author":"Doudican","year":"2013","journal-title":"Anti Cancer Drugs"},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib43","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-07-2159","article-title":"Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells","volume":"6","author":"Doudican","year":"2008","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jss.2013.04.055","article-title":"Inhibition of autophagy with chloroquine is effective in melanoma","volume":"184","author":"Egger","year":"2013","journal-title":"J. Surg. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2011.10.007","article-title":"Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells","volume":"258","author":"Elbaz","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2022.175031_bib46","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3747\/co.27.5223","article-title":"A review of cancer immunotherapy: from the past, to the present, to the future","volume":"27","author":"Esfahani","year":"2020","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib47","doi-asserted-by":"crossref","first-page":"12336","DOI":"10.1038\/ncomms12336","article-title":"Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma","volume":"7","author":"Eskiocak","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib48","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2022.175031_bib209","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Francesco","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib49","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/all.14273","article-title":"Desloratadine and loratadine use associated with improved melanoma survival","volume":"75","author":"Fritz","year":"2020","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib50","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00280-019-03815-4","article-title":"Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF\/VEGFR2 signaling","volume":"83","author":"Gao","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00403-019-01974-1","article-title":"Organogold drug Auranofin exhibits anti-melanogenic activity in B16F10 and MNT-1 melanoma cells","volume":"312","author":"Goenka","year":"2020","journal-title":"Arch. Dermaol. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/1440-1681.13049","article-title":"Inhibition of cancer stem cells promoted by Pimozide","volume":"46","author":"Gon\u00e7alves","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.20892\/j.issn.2095-3941.2018.0375","article-title":"Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics","volume":"16","author":"Grahovac","year":"2019","journal-title":"Cancer. Biol. Med."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175031_bib54","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/cancers11070931","article-title":"Synergy between auranofin and celecoxib against colon cancer in vitro and in vivo through a novel redox-mediated mechanism","volume":"11","author":"Han","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib55","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.18632\/oncotarget.23378","article-title":"The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth","volume":"9","author":"Hanson","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2022.175031_bib56","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jconrel.2021.08.003","article-title":"Advanced nanomedicine approaches applied for treatment of skin carcinoma","volume":"337","author":"Harsimran","year":"2021","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib57","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1038\/s41598-019-51359-7","article-title":"Photodynamic effect of Zirconium phosphate biocompatible nano-bilayers containing methylene blue on cancer and normal cells","volume":"9","author":"Hosseinzadeh","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib58","first-page":"48","article-title":"Effect of nifuroxazide on proliferation, migration, and invasion of thyroid papillary carcinoma cells","volume":"50","author":"Hu","year":"2019","journal-title":"J. Sichuan Univ."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib59","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.18632\/oncotarget.6419","article-title":"Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1\/Waf1-dependent manner","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/or.2015.4380","article-title":"Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo","volume":"35","author":"Hu","year":"2016","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmii.2020.12.008","article-title":"Cancer as an infectious disease: a different treatment alternative using a combination of tigecycline and pyrvinium pamoate - an example of breast cancer","volume":"55","author":"Huang","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib62","first-page":"949","article-title":"The enhanced antitumour response of pimozide combined with the IDO inhibitor L-MT in melanoma","volume":"53","author":"Huijie","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175031_bib63","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.3390\/molecules26113454","article-title":"Quality by design for development, optimization and characterization of Brucine ethosomal gel for skin cancer delivery","volume":"26","author":"Ismail","year":"2021","journal-title":"Molecules"},{"issue":"59","key":"10.1016\/j.ejphar.2022.175031_bib64","doi-asserted-by":"crossref","first-page":"100113","DOI":"10.18632\/oncotarget.22012","article-title":"Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer","volume":"8","author":"Jackson","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2022.175031_bib65","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2018.06.020","article-title":"Use of iontophoresis for the treatment of cancer","volume":"284","author":"James","year":"2018","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib66","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","article-title":"Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice","volume":"151","author":"Jandaghi","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/fcp.12199","article-title":"Tigecycline targets nonsmall cell lung cancer through inhibition of mitochondrial function","volume":"30","author":"Jia","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib68","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1002\/jcb.27719","article-title":"Itraconazole inhibits proliferation of pancreatic cancer cells through activation of Bak-1","volume":"120","author":"Jiang","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib205","article-title":"Berberine inhibits human melanoma A375.S2 cell migration and invasion via affecting the FAK, uPA, and NF-\u03baB signaling pathways and inhibits PLX4032 resistant A375.S2 cell migration in vitro","volume":"23","author":"Jia-fang","year":"2018","journal-title":"Molecules"},{"issue":"35","key":"10.1016\/j.ejphar.2022.175031_bib69","doi-asserted-by":"crossref","first-page":"56456","DOI":"10.18632\/oncotarget.10919","article-title":"Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib70","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1158\/1078-0432.CCR-16-0226","article-title":"Anthelmintic niclosamide disrupts the interplay of p65 and FOXM1\/\u03b2-catenin and eradicates leukemia stem cells in chronic myelogenous leukemia","volume":"23","author":"Jin","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2022.175031_bib71","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jconrel.2020.10.019","article-title":"Controlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery","volume":"329","author":"Jin","year":"2021","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bja.2017.12.043","article-title":"Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model","volume":"121","author":"Johnson","year":"2018","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib73","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"D1","key":"10.1016\/j.ejphar.2022.175031_bib74","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib75","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bjan.2016.08.002","article-title":"Cytotoxic effects of local anesthesia through lidocaine\/ropivacaine on human melanoma cell lines","volume":"66","author":"Kang","year":"2016","journal-title":"Braz. J. Anesthesiol."},{"key":"10.1016\/j.ejphar.2022.175031_bib76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jconrel.2021.08.003","article-title":"Advanced nanomedicine approaches applied for treatment of skin carcinoma","volume":"337","author":"Kaur","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2022.175031_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jare.2021.06.014","article-title":"Skin cancer biology and barriers to treatment: recent applications of polymeric micro\/nanostructures","volume":"36","author":"Khan","year":"2022","journal-title":"J. Adv. Res."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib78","doi-asserted-by":"crossref","DOI":"10.5812\/ijcm.7565","article-title":"Anti-proliferative effects of piroxicam and nimesulide on A431 human squamous carcinoma cell line","volume":"10","author":"Khodaie","year":"2017","journal-title":"Int. J. Cancer Manag."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib79","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3340\/jkns.2021.0068","article-title":"Propranolol inhibits the proliferation of human glioblastoma cell lines through Notch1 and Hes1 signaling system","volume":"64","author":"Kim","year":"2021","journal-title":"J. Kor. Neurosurg Soc."},{"key":"10.1016\/j.ejphar.2022.175031_bib80","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.canlet.2017.10.020","article-title":"Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer","volume":"412","author":"Kim","year":"2018","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib204","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/neuonc\/nop046","article-title":"Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells","volume":"12","author":"Kim","year":"2010","journal-title":"Neuro Oncol"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib81","first-page":"859","article-title":"The influence of ciprofloxacin on viability of A549, HepG2, A375.S2, B16 and C6 cell lines in vitro","volume":"68","author":"Kloskowski","year":"2011","journal-title":"Acta poloniaepharmaceutica"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib82","first-page":"345","article-title":"The influence of ciprofloxacin on hamster ovarian cancer cell line CHO AA8","volume":"67","author":"Kloskowski","year":"2010","journal-title":"Acta Pol. Pharm."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib83","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2013.11.021","article-title":"Metformin is associated with improved survival in endometrial cancer","volume":"132","author":"Ko","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib84","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3892\/mmr.2020.11144","article-title":"Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro","volume":"22","author":"Kobara","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib85","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/2211-5463.12055","article-title":"Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T\u2010cell leukemia cells","volume":"6","author":"Kozako","year":"2016","journal-title":"FEBS Open Bio."},{"issue":"D1","key":"10.1016\/j.ejphar.2022.175031_bib86","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"Kuhn","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2022.175031_bib87","doi-asserted-by":"crossref","first-page":"D876","DOI":"10.1093\/nar\/gkr1011","article-title":"STITCH 3: zooming in on protein-chemical interactions","volume":"40","author":"Kuhn","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2022.175031_bib88","doi-asserted-by":"crossref","first-page":"D684","DOI":"10.1093\/nar\/gkm795","article-title":"STITCH: interaction networks of chemicals and proteins","volume":"36","author":"Kuhn","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2022.175031_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2021.11.015","article-title":"Inhalation delivery of repurposed drugs for lung cancer: approaches, benefits and challenges","volume":"341","author":"Kumbhar","year":"2022","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib90","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41571-019-0313-2","article-title":"New drug approvals in oncology","volume":"17","author":"Kurzrock","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175031_bib91","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/jid.2013.56","article-title":"Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation","volume":"133","author":"Lakhter","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2022.175031_bib92","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175031_bib93","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3390\/jcm9072228","article-title":"Deciphering the molecular landscape of cutaneous squamous cell carcinoma for better diagnosis and treatment","volume":"9","author":"Lazar","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2022.175031_bib94","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ygyno.2015.01.510","article-title":"The effects of itraconazole as anti-cancer agent in epithelial ovarian cancer","volume":"137","author":"Lee","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"7751","key":"10.1016\/j.ejphar.2022.175031_bib95","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1005-x","article-title":"Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism","volume":"568","author":"Lee","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/nov091","article-title":"USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance","volume":"18","author":"Lee","year":"2016","journal-title":"J. Neuro Oncol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib97","first-page":"8","article-title":"Lidocaine suppresses glioma cell proliferation by inhibiting TRPM7 channels","volume":"9","author":"Leng","year":"2017","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib98","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.18632\/oncotarget.6516","article-title":"Auranofin-mediated inhibition of PI3K\/AKT\/mTOR axis and anticancer activity in non-small cell lung cancer cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib99","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2015.09.140","article-title":"Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt\/\u03b2-catenin signaling","volume":"467","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/bib\/bbv020","article-title":"A survey of current trends in computational drug repositioning","volume":"17","author":"Li","year":"2016","journal-title":"Brief. Brief. Brief. Bioinf."},{"issue":"22","key":"10.1016\/j.ejphar.2022.175031_bib101","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1038\/s41388-018-0172-9","article-title":"Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.ejphar.2022.175031_bib102","doi-asserted-by":"crossref","first-page":"28510","DOI":"10.18632\/oncotarget.15324","article-title":"Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K\/mTOR signaling pathways","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib103","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/1568009615666150629132157","article-title":"The anthelmintic drug niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways","volume":"15","author":"Liao","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178937","article-title":"Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13046-019-1303-z","article-title":"Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy","volume":"38","author":"Lin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.ejphar.2022.175031_bib106","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/pros.23015","article-title":"Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition: niclosamide Inhibits Stat3 and Cell Migration","volume":"75","author":"Liu","year":"2015","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib107","first-page":"880","article-title":"Chemotherapy targeting cancer stem cells","volume":"5","author":"Liu","year":"2015","journal-title":"Am. J Cancer Res."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23082019","article-title":"Berberine inhibits human melanoma A375.S2 cell migration and invasion via affecting the FAK, uPA, and NF-\u03baB signaling pathways and inhibits PLX4032 resistant A375.S2 cell migration in vitro","volume":"23","author":"Liu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2022.175031_bib109","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.12659\/MSM.913069","volume":"25","author":"Liu","year":"2019","journal-title":"Med. Sci. Mon."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13046-020-1539-7","article-title":"Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications","volume":"39","author":"Liu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib111","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib112","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s10637-019-00724-4","article-title":"Nifuroxazide induces apoptosis, inhibits cell migration and invasion in osteosarcoma","volume":"37","author":"Luo","year":"2019","journal-title":"Invest. N. Drugs"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib113","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1871523018666190911121306","article-title":"Tegaserod for the treatment of irritable bowel syndrome","volume":"19","author":"Madia","year":"2020","journal-title":"Antiinflamm Antiallergy Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib114","article-title":"Chloroquine and hydroxychloroquine for cancer therapy","volume":"1","author":"Manic","year":"2014","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.ejphar.2022.175031_bib115","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3389\/fonc.2020.01693","article-title":"Efavirenz and lopinavir\/ritonavir alter cell cycle regulation in lung cancer","volume":"10","author":"Marima","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2022.175031_bib116","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2020.11.047","article-title":"New tricks of old drugs: repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies","volume":"329","author":"Mei","year":"2021","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib117","doi-asserted-by":"crossref","DOI":"10.4161\/onci.23082","article-title":"Trial watch: cardiac glycosides and cancer therapy: cardiac glycosides and cancer therapy","volume":"2","author":"Menger","year":"2013","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib118","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.1038\/srep08202","article-title":"Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen","volume":"5","author":"Michaelis","year":"2015","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.ejphar.2022.175031_bib119","doi-asserted-by":"crossref","first-page":"18074","DOI":"10.1021\/acsami.9b01343","article-title":"Pro-nifuroxazide self-assembly leads to triggerable nanomedicine for anti-cancer therapy","volume":"11","author":"Misra","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12032-021-01475-0","article-title":"The effect of itraconazole on the clinical outcomes of patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a randomized controlled study","volume":"38","author":"Mohamed","year":"2021","journal-title":"Med. Oncol."},{"issue":"19","key":"10.1016\/j.ejphar.2022.175031_bib121","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1016\/j.bmc.2016.07.070","article-title":"New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2\/M phase","volume":"24","author":"Mohammed","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib122","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1535-7163.MCT-05-0117","article-title":"Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects","volume":"5","author":"Mohammed","year":"2006","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2022.175031_bib123","article-title":"Methylene blue and photodynamic therapy for melanomas: inducing different rates of cell death (necrosis and apoptosis) in B16-F10 melanoma cells according to methylene blue concentration and energy dose","volume":"37","author":"Murilo","year":"2022","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.ejphar.2022.175031_bib124","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fphar.2018.00583","article-title":"DeCoST: a new approach in drug repurposing from control system theory","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejphar.2022.175031_bib125","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00432-013-1539-5","article-title":"Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer","volume":"139","author":"Nygren","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175031_bib127","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.21873\/anticanres.13793","article-title":"Lopinavir-ritonavir combination induces endoplasmic reticulum stress and kills urological cancer cells","volume":"39","author":"Okubo","year":"2019","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib128","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1208\/s12248-012-9390-1","article-title":"Drug repurposing: far beyond new targets for old drugs","volume":"14","author":"Oprea","year":"2012","journal-title":"AAPS J."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175031_bib201","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc.2017.43","article-title":"Melanoma: a global perspective","volume":"17","author":"Ossio","year":"2017","journal-title":"Nat. Rev. Cancer."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib129","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3892\/or.2017.5977","article-title":"Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest","volume":"38","author":"Oura","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib208","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jdermsci.2010.04.013","article-title":"Eugenol restricts DMBA croton oil induced skin carcinogenesis in mice: Downregulation of c-Myc and H-ras, and activation of p53 dependent apoptotic pathway","volume":"59","author":"Pal","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejphar.2022.175031_bib130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3332\/ecancer.2014.485","article-title":"Repurposing drugs in oncology (ReDO)-mebendazole as an anti-cancer agent","volume":"8","author":"Pantziarka","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.ejphar.2022.175031_bib131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3332\/ecancer.2015.521","article-title":"Repurposing drugs in oncology (ReDO)-itraconazole as an anti-cancer agent","volume":"9","author":"Pantziarka","year":"2015","journal-title":"Ecancermedicalscience"},{"issue":"9","key":"10.1016\/j.ejphar.2022.175031_bib132","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1111\/cas.14124","article-title":"Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer","volume":"110","author":"Park","year":"2019","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib133","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pan.2016.03.005","article-title":"Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade","volume":"16","author":"Partecke","year":"2016","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib134","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s10637-019-00733-3","article-title":"Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo","volume":"37","author":"Paskas","year":"2019","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejphar.2022.175031_bib135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ebiom.2016.02.026","article-title":"Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a bench to bedside study","volume":"6","author":"Pasquier","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/dkw364","article-title":"Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects","volume":"72","author":"Pietsch","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib137","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib138","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tips.2009.11.006","article-title":"Unveiling the role of network and systems biology in drug discovery","volume":"31","author":"Pujol","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2022.175031_bib139","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2015.04.015","article-title":"Transcutaneous delivery of leflunomide nanoemulgel: mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity","volume":"487","author":"Pund","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib141","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.pharep.2015.05.012","article-title":"Piroxicam, a traditional non-steroidal anti-inflammatory drug (NSAID) causes apoptosis by ROS mediated Akt activation","volume":"67","author":"Rai","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175031_bib207","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/cam4.845","article-title":"A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia","volume":"5","author":"Reed","year":"2016","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib142","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.3892\/mmr.2017.7755","article-title":"Leflunomide inhibits proliferation and tumorigenesis of oral squamous cell carcinoma","volume":"16","author":"Ren","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2022.175031_bib143","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.lfs.2018.08.027","article-title":"Pimozide suppresses colorectal cancer via inhibition of Wnt\/\u03b2-catenin signaling pathway","volume":"209","author":"Ren","year":"2018","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175031_bib144","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/acs.molpharmaceut.7b00764","article-title":"Drug repurposing approach identifies a synergistic drug combination of an antifungal agent and an experimental organometallic drug for melanoma treatment","volume":"15","author":"Riedel","year":"2018","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib146","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.sopen.2019.05.004","article-title":"Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models","volume":"1","author":"Rios Perez","year":"2019","journal-title":"Surgery Open Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib147","first-page":"13","article-title":"Auranofin: repurposing an old drug for a golden new age Drugs","volume":"15","author":"Roder","year":"2015","journal-title":"Inside R"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib148","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2230.1979.tb01656.x","article-title":"Haloprogin as treatment for fungal infections","volume":"4","author":"Rudolph","year":"1979","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejphar.2022.175031_bib149","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.biopha.2018.08.095","article-title":"Anticancer activity of methylene blue via inhibition of heat shock protein 70","volume":"107","author":"Sanchala","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.ejphar.2022.175031_bib150","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.chembiol.2018.09.005","article-title":"ALDH1 bio-activates nifuroxazide to eradicate ALDHHigh melanoma-initiating cells","volume":"25","author":"Sarvi","year":"2018","journal-title":"Cell. Chem. Biol."},{"issue":"14","key":"10.1016\/j.ejphar.2022.175031_bib151","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1158\/1078-0432.CCR-15-2256","article-title":"Identification of niclosamide as a novel anticancer agent for adrenocortical carcinoma","volume":"22","author":"Satoh","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2022.175031_bib152","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11010-017-3084-z","article-title":"Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: a strategy for repurposing a phase I clinical trial drug","volume":"436","author":"Sau","year":"2017","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2022.175031_bib203","series-title":"experimental and molecular therapeutics","article-title":"Abstract 2958: Evaluating the therapeutic effects of methylene blue against prostate cancer","author":"Shanthi","year":"2019"},{"issue":"10","key":"10.1016\/j.ejphar.2022.175031_bib153","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175031_bib154","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7150\/ijbs.9224","article-title":"Recent advances in drug repositioning for the discovery of new anticancer drugs","volume":"10","author":"Shim","year":"2014","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib155","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3858\/emm.2008.40.5.486","article-title":"Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase\/Akt\/Rac1 signal pathway","volume":"40","author":"Shin","year":"2008","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib200","first-page":"7","volume":"70","author":"Siegel","year":"2020","journal-title":"Cancer statistics, CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib156","doi-asserted-by":"crossref","first-page":"12576","DOI":"10.18632\/oncotarget.14990","article-title":"The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma","volume":"8","author":"Simbulan-Rosenthal","year":"2017","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/j.ejphar.2022.175031_bib157","doi-asserted-by":"crossref","first-page":"16792","DOI":"10.18632\/oncotarget.24698","article-title":"STAT5 inhibition induces TRAIL\/DR4 dependent apoptosis in peripheral T-cell lymphoma","volume":"9","author":"Simpson","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2022.175031_bib158","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"43","key":"10.1016\/j.ejphar.2022.175031_bib159","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Proc. Natl. Acad. Sci U. S. A."},{"issue":"8","key":"10.1016\/j.ejphar.2022.175031_bib160","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.jid.2017.03.033","article-title":"Phenformin inhibits myeloid-derived suppressor cells and enhances the anti-tumor activity of PD-1 blockade in melanoma","volume":"137","author":"Sun","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2022.175031_bib161","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib162","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2017.01.021","article-title":"Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage","volume":"483","author":"Tan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib163","first-page":"106","article-title":"Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironment","volume":"24","author":"Tat","year":"2019","journal-title":"J. Buon"},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib164","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.7314\/APJCP.2015.16.5.2031","article-title":"Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells","volume":"16","author":"Thongchot","year":"2015","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"9","key":"10.1016\/j.ejphar.2022.175031_bib165","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1038\/cddis.2011.86","article-title":"Metformin inhibits melanoma development through autophagy and apoptosis mechanisms","volume":"2","author":"Tomic","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2022.175031_bib166","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jconrel.2021.03.005","article-title":"Not only in silico drug discovery: molecular modeling towards in silico drug delivery formulations","volume":"332","author":"Tommaso","year":"2021","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib167","doi-asserted-by":"crossref","first-page":"831","DOI":"10.18632\/oncotarget.5704","article-title":"Auranofin is a potent suppressor of osteosarcoma metastasis","volume":"7","author":"Topkas","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib168","doi-asserted-by":"crossref","first-page":"515","DOI":"10.21873\/anticanres.11343","article-title":"Itraconazole inhibits AKT\/mTOR signaling and proliferation in endometrial cancer cells","volume":"37","author":"Tsubamoto","year":"2017","journal-title":"Anticancer Res."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175031_bib169","first-page":"4923","article-title":"Impact of itraconazole after first-line chemotherapy on survival of patients with metastatic biliary tract cancer","volume":"35","author":"Tsubamoto","year":"2015","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib170","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3892\/ol.2017.6325","article-title":"Repurposing itraconazole as an anticancer agent","volume":"14","author":"Tsubamoto","year":"2017","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib171","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s12668-021-00880-z","article-title":"Anticarcinogenic effect of chitosan nanoparticles containing Syzygiumaromaticum essential oil or eugenol toward breast and skin cancer cell lines","volume":"11","author":"Valizadeh","year":"2021","journal-title":"BioNanoScience"},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib172","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.celrep.2019.03.067","article-title":"Phenformin, but not metformin, delays development of T cell acute lymphoblastic leukemia\/lymphoma via cell-autonomous AMPK activation","volume":"27","author":"Vara-Ciruelos","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2022.175031_bib173","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2014.10.032","article-title":"Mathematical model accurately predicts protein release from an affinity-based delivery system","volume":"197","author":"Vulic","year":"2015","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib174","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1515\/biol-2018-0029","article-title":"Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway","volume":"13","author":"Wang","year":"2018","journal-title":"Open Life Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib175","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/aps.2016.39","article-title":"Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"7339","key":"10.1016\/j.ejphar.2022.175031_bib176","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature09882","article-title":"DHODH modulates transcriptional elongation in the neural crest and melanoma","volume":"471","author":"White","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2022.175031_bib177","doi-asserted-by":"crossref","first-page":"683241","DOI":"10.3389\/fonc.2021.683241","article-title":"Tegaserod maleate inhibits esophageal squamous cell carcinoma proliferation by suppressing the peroxisome pathway","volume":"11","author":"Wu","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib178","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/ALN.0000000000001528","article-title":"Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo","volume":"126","author":"Xing","year":"2017","journal-title":"Anesthesiolol"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib179","first-page":"949","article-title":"Effect of lidocaine on the safety of postoperative skin reconstruction after malignant melanoma resection","volume":"18","author":"Xu","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib206","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12885-015-1560-y","article-title":"Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation","volume":"15","author":"Yadav","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175031_bib180","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1039\/C8FO02013B","article-title":"Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K\/AKT pathway","volume":"10","author":"Yao","year":"2019","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175031_bib181","first-page":"212","article-title":"Anti-tumor effects of lidocaine on human gastric cancer cells in vitro","volume":"120","author":"Ye","year":"2019","journal-title":"Bratisl. Lek. Listy"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib182","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.452","article-title":"Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis","volume":"8","author":"Ye","year":"2017","journal-title":"Cell Death Dis."},{"issue":"27","key":"10.1016\/j.ejphar.2022.175031_bib183","doi-asserted-by":"crossref","first-page":"42126","DOI":"10.18632\/oncotarget.9704","article-title":"Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt\/\u03b2-catenin signaling","volume":"7","author":"Yin","year":"2016","journal-title":"Oncotarget"},{"issue":"45","key":"10.1016\/j.ejphar.2022.175031_bib184","doi-asserted-by":"crossref","first-page":"18226","DOI":"10.1073\/pnas.1317577110","article-title":"Phenformin enhances the therapeutic benefit of BRAF (V600E) inhibition in melanoma","volume":"110","author":"Yuan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"4","key":"10.1016\/j.ejphar.2022.175031_bib185","first-page":"5652","article-title":"Anticancer activity of caffeic acid n-butyl ester against A431 skin carcinoma cell line occurs via induction of apoptosis and inhibition of the mTOR\/PI3K\/AKT signaling pathway","volume":"17","author":"Zeng","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2022.175031_bib186","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","article-title":"Ciprofloxacin derivatives and their antibacterial activities","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib187","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijrobp.2018.08.046","article-title":"Mebendazole potentiates radiation therapy in triple-negative breast cancer","volume":"3","author":"Zhang","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175031_bib188","article-title":"Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A Cell","volume":"50","author":"Zhang","year":"2017","journal-title":"Prolif"},{"key":"10.1016\/j.ejphar.2022.175031_bib189","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2020.11.047","article-title":"New tricks of old drugs: repurposing non-chemo drugs and dietary phytochemicals as adjuvants in anti-tumor therapies","volume":"329","author":"Zhang","year":"2021","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.ejphar.2022.175031_bib190","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2337\/dc11-0512","article-title":"Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis","volume":"34","author":"Zhang","year":"2011","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib191","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib192","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1186\/s40064-016-3153-x","article-title":"Niclosamide suppresses renal cell carcinoma by inhibiting Wnt\/\u03b2-catenin and inducing mitochondrial dysfunctions","volume":"5","author":"Zhao","year":"2016","journal-title":"Springer Plus"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib193","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.3892\/or.2017.5629","article-title":"Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma","volume":"37","author":"Zhao","year":"2017","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175031_bib194","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1007\/s13277-015-4613-6","article-title":"Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo","volume":"37","author":"Zhong","year":"2016","journal-title":"Tumour Biol."},{"issue":"42","key":"10.1016\/j.ejphar.2022.175031_bib195","doi-asserted-by":"crossref","first-page":"68314","DOI":"10.18632\/oncotarget.11599","article-title":"Propranolol induced G0\/G1\/S phase arrest and apoptosis in melanoma cells via AKT\/MAPK pathway","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib196","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3892\/ijo.2015.3229","article-title":"The antipsychotic drug pimozide inhibits cell growth in prostate cancer through suppression of STAT3 activation","volume":"48","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2022.175031_bib197","doi-asserted-by":"crossref","first-page":"D1128","DOI":"10.1093\/nar\/gkr797","article-title":"Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery","volume":"40","author":"Zhu","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175031_bib198","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12871-020-01039-1","article-title":"Differential effects and mechanisms of local anesthetics on esophageal carcinoma cell migration, growth, survival and chemosensitivity","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Anesthesiol."},{"key":"10.1016\/j.ejphar.2022.175031_bib199","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bcp.2019.08.012","article-title":"Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway","volume":"169","author":"Zhu","year":"2019","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922002928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922002928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:03:02Z","timestamp":1757977382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922002928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":207,"alternative-id":["S0014299922002928"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175031","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing: An emerging strategy in alleviating skin cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175031"}}